Moderna
MRNA
#1122
Rank
$21.50 B
Marketcap
$54.20
Share price
-0.28%
Change (1 day)
110.89%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -$3.12 Billion USD

According to Moderna 's latest financial reports the company's current earnings are $2.20 Billion USD. In 2025 the company made an earning of -$2.76 Billion USD, an increase over its 2024 earnings that were of -$3.59 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$3.12 Billion12.84%
2025 -$2.76 Billion-23.03%
2024 -$3.59 Billion-8.22%
2023 -$3.91 Billion-140.65%
2022 $9.60 B-27.81%
2021 $13.30 B-1911.15%
2020 -$0.74 Billion44.7%
2019 -$0.51 Billion28.63%
2018 -$0.4 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$25.97 B-934.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$15.78 B-607.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
$13.15 B-522.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-$47.43 Million-98.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-$0.12 Billion-96.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-$41.77 Million-98.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$0.86 B-127.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
$0.34 B-111.09%๐Ÿ‡บ๐Ÿ‡ธ USA